Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-040723

Horizon Pharma plc · HZNP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John B Thomas
Officer — EVP, Corporate Strategy and IR
Period of report
May 6, 2015
Accepted (ET)
May 8, 2015 · 6:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$28.53May 6, 2015A83,000A—May 5, 2025Ordinary Shares83,00083,000D
Restricted Stock UnitsF2—May 6, 2015A37,500A——Ordinary Shares37,50037,500D
Performance Share Units (PSU)F3—May 6, 2015A150,000A——Ordinary Shares150,000150,000D
Performance Share Units (PSU)F3—May 6, 2015A450,000A——Ordinary Shares450,000450,000D

Explanation of responses